Comparative risk of venous thromboembolism amongst users of different anti-osteoporosis drugs in the uk: a propensity-matched cohort study using data from the clinical practice research datalink
Despite known safety profile of antiosteoporosis drugs (AODs) based on randomized controlled trials (RCTs) [1–4], recent alerts have demonstrated a need for data on the safety of these drugs in actual practice conditions and in NHS patients [5, 6].
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Conference item |
| Published: |
Springer Verlag
2016
|